Chen, L.; Chiang, Y.C.; Chan, L.S.; Chau, W.Y.; Lung, M.L.; Kahn, M.; Lo, K.W.; Mak, N.K.; Lung, H.L.
The CBP/β-Catenin Antagonist, ICG-001, Inhibits Tumor Metastasis via Blocking of the miR-134/ITGB1 Axis-Mediated Cell Adhesion in Nasopharyngeal Carcinoma. Cancers 2022, 14, 3125.
https://doi.org/10.3390/cancers14133125
AMA Style
Chen L, Chiang YC, Chan LS, Chau WY, Lung ML, Kahn M, Lo KW, Mak NK, Lung HL.
The CBP/β-Catenin Antagonist, ICG-001, Inhibits Tumor Metastasis via Blocking of the miR-134/ITGB1 Axis-Mediated Cell Adhesion in Nasopharyngeal Carcinoma. Cancers. 2022; 14(13):3125.
https://doi.org/10.3390/cancers14133125
Chicago/Turabian Style
Chen, Luo, Yiu Chun Chiang, Lai Sheung Chan, Wai Yin Chau, Maria Li Lung, Michael Kahn, Kwok Wai Lo, Nai Ki Mak, and Hong Lok Lung.
2022. "The CBP/β-Catenin Antagonist, ICG-001, Inhibits Tumor Metastasis via Blocking of the miR-134/ITGB1 Axis-Mediated Cell Adhesion in Nasopharyngeal Carcinoma" Cancers 14, no. 13: 3125.
https://doi.org/10.3390/cancers14133125
APA Style
Chen, L., Chiang, Y. C., Chan, L. S., Chau, W. Y., Lung, M. L., Kahn, M., Lo, K. W., Mak, N. K., & Lung, H. L.
(2022). The CBP/β-Catenin Antagonist, ICG-001, Inhibits Tumor Metastasis via Blocking of the miR-134/ITGB1 Axis-Mediated Cell Adhesion in Nasopharyngeal Carcinoma. Cancers, 14(13), 3125.
https://doi.org/10.3390/cancers14133125